Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04192136 · ClinicalTrials.gov registry record · NA
NAD+ and Exercise in FA
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT04192136 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 75 participants.
The verdict
NCT04192136, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
Randomized, placebo-controlled trial with a 2x2 factorial design testing the effects of an NAD+ precursor (NR) and exercise on Peak VO2 and Si in Friedreich's Ataxia (FA). The primary objective of this research is to measure the effect of combination administration (NR + exercise) on aerobic capacity (Peak VO2) in FA. A key secondary objective is to measure the effect of combination administration (NR + exercise) on glucose homeostasis (Si) in FA.
Interventions
- DIETARY_SUPPLEMENT Placebo
- OTHER Exercise Intervention
- DIETARY_SUPPLEMENT Nicotinamide Riboside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-09-03 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04192136
The ClinicalTrials.gov registry entry for NCT04192136 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04192136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04192136 about?
NCT04192136 is a clinical study titled "NAD+ and Exercise in FA". Randomized, placebo-controlled trial with a 2x2 factorial design testing the effects of an NAD+ precursor (NR) and exercise on Peak VO2 and Si in Friedreich's Ataxia (FA). The primary objective of this research is to measure the effect of combination administration (NR + exercise) on aerobic capaci...
What is the current status of trial NCT04192136?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2020-09-03. Estimated completion is 2025-10-31.
What interventions are being tested in trial NCT04192136?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Exercise Intervention (OTHER), Nicotinamide Riboside (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04192136?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.